Pasithea has acquired 2 companies, including 2 in the last 5 years.
Pasithea’s largest acquisition to date was in 2022, when it acquired Alpha-5 Integrin for $4M. Pasithea has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
1111 Lincoln Road, Suite 500,
Miami Beach, Florida
33139
United States,
(786) 977-3380
www.pasithea.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-10-12 |
AlloMek Therapeutics · Life Science
Woodbridge, Connecticut · www.allomek.com AlloMek Therapeutics is a biotechnology company that provides CIP-137401, a potential macrocyclic mitogen-activated protein kinase kinase 1/2 (MEK) inhibitor for use in a range of CNS-related indications, including neurofibromatosis type 1 (NF1) and Noonan syndrome, as well as potential synergy with its existing multiple sclerosis (MS) development program. AlloMek Therapeutics is based in Woodbridge, Connecticut. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
